Trial Profile
A Phase II Study to Evaluate the Efficacy and Safety of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2019
Price :
$35
*
At a glance
- Drugs Faropenem (Primary) ; Ertapenem
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- 27 Jun 2013 New trial record